Cellectar Biosciences (CLRB) Q2 2025 Earnings

13MayConfirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-4.9
-3.29
-1.68
-0.07

Details

Expected EPS
-4.9
Actual EPS
-4.2
Surprise EPS
0.7
Surprise Percent
+14.29%

Description

Cellectar Biosciences (CLRB) has reported earnings of -4.2 per share for Q2 2025.

0 Comments

Share your thoughts